| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Immunovirologie Moléculaire et Cellulaire, CNRS-UMR30, Faculté de Médicine Alexis Carrel, Rue Paradin, 69372 Lyon Cédex 08
2 INSERM U74, Université Louis Pasteur, 3 Rue Koeberlé, 67000 Strasbourg
and3 Transgène, 11 rue de Molsheim, 67000 Strasbourg, France
Measles virus genes encoding the haemagglutinin (HA), fusion protein (F) or nucleoprotein (NP) have been inserted into the vaccinia virus genome either alone or in various combinations. In each case the measles virus genes were expressed from the 7.5K promoter and were incorporated into the thymidine kinase (tk) or K1L loci of the Copenhagen strain of vaccinia virus. Cells infected by the recombinants synthesized measles virus proteins indistinguishable from those induced in measles virus-infected cells. However, in some instances the level of expression in cells infected by recombinants expressing more than one measles virus gene was reduced when compared to those encoding a single gene. The sera from mice immunized with recombinants containing either HA, HA.F, HA.NP or HA.F.NP had similar levels of measles virus neutralizing antibodies which remained constant throughout a 7 month period. Analysis of these sera by immunoprecipitation of radiolabelled measles virus confirmed the presence of specific antibody to each of the antigens where appropriate. The introduction of the measles virus genes into the K1L and the tk sites despite attenuating the virus for mice by 10-fold and 1000-fold respectively did not affect the vaccination efficiency, i.e. ability to induce measles virus antibody and protect mice. Vaccination of BALB/c (H2d) mice with HA and F, but not NP, recombinants completely protected the animals against a lethal measles virus challenge. In contrast, although the HA recombinant protected CBA (H2k) mice, the F recombinant did so poorly. However, by immunizing CBA mice with a recombinant expressing both F and NP, protection was increased to more than 75%. Our findings demonstrate the ability of three measles virus antigens expressed from the vaccinia virus genome alone or in combination to contribute to protective immunity against measles virus infection of mice. They also suggest that the association of measles virus antigens in a single recombinant DNA vaccine could be beneficial to overcome host-related restriction of the immune response to particular antigens.
Present address: Unité d'Immunologie et Stratégie Vaccinale, Institut Pasteur, 69365 Lyon Cedex 07, France
Received 22 August 1991;
accepted 15 October 1991.
This article has been cited by other articles:
|
|
 |
|
  J. C. Marie, F. Saltel, J.-M. Escola, P. Jurdic, T. F. Wild, and B. Horvat Cell Surface Delivery of the Measles Virus Nucleoprotein: a Viral Strategy To Induce Immunosuppression J. Virol., November 1, 2004; 78(21): 11952 - 11961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vincent, I. Tigaud, H. Schneider, C. J. Buchholz, Y. Yanagi, and D. Gerlier Restriction of Measles Virus RNA Synthesis by a Mouse Host Cell Line: trans-Complementation by Polymerase Components or a Human Cellular Factor(s) J. Virol., May 13, 2002; 76(12): 6121 - 6130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. de Carvalho Nicacio, R. A. Williamson, P. W. H. I. Parren, A. Lundkvist, D. R. Burton, and E. Bjorling Neutralizing Human Fab Fragments against Measles Virus Recovered by Phage Display J. Virol., January 1, 2002; 76(1): 251 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Skiadopoulos, S. R. Surman, J. M. Riggs, P. L. Collins, and B. R. Murphy A Chimeric Human-Bovine Parainfluenza Virus Type 3 Expressing Measles Virus Hemagglutinin Is Attenuated for Replication but Is Still Immunogenic in Rhesus Monkeys J. Virol., November 1, 2001; 75(21): 10498 - 10504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Vincent, D. Gerlier, and S. N. Manié Measles Virus Assembly within Membrane Rafts J. Virol., November 1, 2000; 74(21): 9911 - 9915. [Abstract] [Full Text]
|
|
|
|
|
|
A. P. Durbin, M. H. Skiadopoulos, J. M. McAuliffe, J. M. Riggs, S. R. Surman, P. L. Collins, and B. R. Murphy Human Parainfluenza Virus Type 3 (PIV3) Expressing the Hemagglutinin Protein of Measles Virus Provides a Potential Method for Immunization against Measles Virus and PIV3 in Early Infancy J. Virol., August 1, 2000; 74(15): 6821 - 6831. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. E. H. Coupar, P. G. Oke, and M. E. Andrew Insertion sites for recombinant vaccinia virus construction: effects on expression of a foreign protein J. Gen. Virol., February 1, 2000; 81(2): 431 - 439. [Abstract] [Full Text]
|
|
|
|
|
|
L. Kutinová, V. Ludví ková, L. Maresov á, s. Neme cková, J. Broucek, P. Hainz, and V. Vonka Effect of virulence on immunogenicity of single and double vaccinia virus recombinants expressing differently immunogenic antigens: antibody-response inhibition induced by immunization with a mixture of recombinants differing in virulence J. Gen. Virol., November 1, 1999; 80(11): 2901 - 2908. [Abstract] [Full Text]
|
|
|
|
|
|
S. Niewiesk, H. Ohnimus, J.-J. Schnorr, M. Götzelmann, S. Schneider-Schaulies, C. Jassoy, and V. ter Meulen Measles virus-induced immunosuppression in cotton rats is associated with cell cycle retardation in uninfected lymphocytes J. Gen. Virol., August 1, 1999; 80(8): 2023 - 2029. [Abstract] [Full Text]
|
|
|
|
|
|
N. Sixt, A. Cardoso, A. Vallier, J. Fayolle, R. Buckland, and T. F. Wild Canine Distemper Virus DNA Vaccination Induces Humoral and Cellular Immunity and Protects against a Lethal Intracerebral Challenge J. Virol., November 1, 1998; 72(11): 8472 - 8476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bouche, W. Ammerlaan, F. Berthet, S. Houard, F. Schneider, and C. P. Muller Immunosorbent Assay Based on Recombinant Hemagglutinin Protein Produced in a High-Efficiency Mammalian Expression System for Surveillance of Measles Immunity J. Clin. Microbiol., March 1, 1998; 36(3): 721 - 726. [Abstract] [Full Text]
|
|
|
|
|
|
A. I. Cardoso, N. Sixt, A. Vallier, J. Fayolle, R. Buckland, and T. F. Wild Measles Virus DNA Vaccination: Antibody Isotype Is Determined by the Method of Immunization and by the Nature of both the Antigen and the Coimmunized Antigen J. Virol., March 1, 1998; 72(3): 2516 - 2518. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
